instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Hypoalbuminaemia'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Hypokalaemia'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Hypomagnesaemia'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Pseudohyperphosphataemia'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Respiratory alkalosis'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 18,805,645 | 2021 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduce... | Recovered | ReactionOutcome | CC BY | 34046068 | 19,436,312 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.
Multiple myeloma (MM) poses inherent risk of thrombosis that can be amplified by the use of immunomodulator therapy. We present a patient with MM who was being treated with lenalidomide and dexamethasone when he developed progr... | LENALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34046102 | 19,379,154 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.
Multiple myeloma (MM) poses inherent risk of thrombosis that can be amplified by the use of immunomodulator therapy. We present a patient with MM who was being treated with lenalidomide and dexamethasone when he developed progr... | LENALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34046102 | 19,379,154 | 2021-06 |
What was the administration route of drug 'DEXAMETHASONE'? | Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.
Multiple myeloma (MM) poses inherent risk of thrombosis that can be amplified by the use of immunomodulator therapy. We present a patient with MM who was being treated with lenalidomide and dexamethasone when he developed progr... | Oral | DrugAdministrationRoute | CC BY-NC | 34046102 | 19,405,914 | 2021-06 |
What was the administration route of drug 'LENALIDOMIDE'? | Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.
Multiple myeloma (MM) poses inherent risk of thrombosis that can be amplified by the use of immunomodulator therapy. We present a patient with MM who was being treated with lenalidomide and dexamethasone when he developed progr... | Oral | DrugAdministrationRoute | CC BY-NC | 34046102 | 19,379,154 | 2021-06 |
What was the outcome of reaction 'Pulmonary venous thrombosis'? | Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.
Multiple myeloma (MM) poses inherent risk of thrombosis that can be amplified by the use of immunomodulator therapy. We present a patient with MM who was being treated with lenalidomide and dexamethasone when he developed progr... | Recovering | ReactionOutcome | CC BY-NC | 34046102 | 19,379,154 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute cutaneous lupus erythematosus'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bicytopenia'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blister'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cheilitis'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epidermal necrosis'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nikolsky^s sign'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Reticular erythematous mucinosis'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin laceration'. | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Acute cutaneous lupus erythematosus'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Anaemia'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Bicytopenia'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Blister'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Cheilitis'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Dermatitis'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Epidermal necrosis'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Erythema'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Leukopenia'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Nikolsky^s sign'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Oedema'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Proteinuria'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Rash'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Reticular erythematous mucinosis'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
What was the outcome of reaction 'Skin laceration'? | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report.
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus (TEN-like ACLE) is a rare manifestation of systemic lupus erythematosus (SLE). Because of its rarity, little is known about this entity. In this report, we describe ... | Recovered | ReactionOutcome | CC BY | 34046141 | 19,819,062 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lichenoid keratosis'. | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | ACETAMINOPHEN, ATORVASTATIN, CALCIUM, CELECOXIB, CLOXACILLIN, DURVALUMAB, FUROSEMIDE, LEVOTHYROXINE, PREDNISONE, PREGABALIN, VITAMIN D NOS | DrugsGivenReaction | CC BY-NC | 34046182 | 19,663,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin toxicity'. | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | CELECOXIB, DURVALUMAB, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34046182 | 19,489,092 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | ACETAMINOPHEN, ATORVASTATIN, CALCIUM, CELECOXIB, CLOXACILLIN, DURVALUMAB, FUROSEMIDE, LEVOTHYROXINE, PREDNISONE, PREGABALIN, VITAMIN D NOS | DrugsGivenReaction | CC BY-NC | 34046182 | 19,663,467 | 2021 |
What is the weight of the patient? | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | 68 kg. | Weight | CC BY-NC | 34046182 | 19,663,467 | 2021 |
What was the administration route of drug 'DURVALUMAB'? | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | Other | DrugAdministrationRoute | CC BY-NC | 34046182 | 19,663,467 | 2021 |
What was the administration route of drug 'FUROSEMIDE'? | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34046182 | 19,663,467 | 2021 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.
Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related advers... | Recovered | ReactionOutcome | CC BY-NC | 34046182 | 19,663,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Lisinopril-Induced Acute Necrotizing Pancreatitis.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is used as one of the first-line antihypertensive medications. Necrotizing pancreatitis induced by the use of ACE inhibitors is an extremely rare occurrence. Although an uncommon risk factor, our aim i... | LISINOPRIL | DrugsGivenReaction | CC BY | 34046276 | 19,534,380 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis necrotising'. | Lisinopril-Induced Acute Necrotizing Pancreatitis.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is used as one of the first-line antihypertensive medications. Necrotizing pancreatitis induced by the use of ACE inhibitors is an extremely rare occurrence. Although an uncommon risk factor, our aim i... | LISINOPRIL | DrugsGivenReaction | CC BY | 34046276 | 19,377,408 | 2021-04-23 |
What was the administration route of drug 'LISINOPRIL'? | Lisinopril-Induced Acute Necrotizing Pancreatitis.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is used as one of the first-line antihypertensive medications. Necrotizing pancreatitis induced by the use of ACE inhibitors is an extremely rare occurrence. Although an uncommon risk factor, our aim i... | Oral | DrugAdministrationRoute | CC BY | 34046276 | 19,377,408 | 2021-04-23 |
What was the outcome of reaction 'Drug hypersensitivity'? | Lisinopril-Induced Acute Necrotizing Pancreatitis.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is used as one of the first-line antihypertensive medications. Necrotizing pancreatitis induced by the use of ACE inhibitors is an extremely rare occurrence. Although an uncommon risk factor, our aim i... | Recovered | ReactionOutcome | CC BY | 34046276 | 19,534,380 | 2021-04-23 |
What was the outcome of reaction 'Pancreatitis necrotising'? | Lisinopril-Induced Acute Necrotizing Pancreatitis.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is used as one of the first-line antihypertensive medications. Necrotizing pancreatitis induced by the use of ACE inhibitors is an extremely rare occurrence. Although an uncommon risk factor, our aim i... | Recovered | ReactionOutcome | CC BY | 34046276 | 19,377,408 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory distress syndrome'. | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | HYDROXYUREA | DrugsGivenReaction | CC BY | 34046361 | 19,463,057 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspiration'. | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | HYDROXYUREA | DrugsGivenReaction | CC BY | 34046361 | 19,463,057 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | SORAFENIB | DrugsGivenReaction | CC BY | 34046361 | 20,096,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | HYDROXYUREA | DrugsGivenReaction | CC BY | 34046361 | 19,463,057 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | SORAFENIB | DrugsGivenReaction | CC BY | 34046361 | 20,096,654 | 2021 |
What was the administration route of drug 'CYTARABINE'? | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | Subcutaneous | DrugAdministrationRoute | CC BY | 34046361 | 20,052,917 | 2021 |
What was the outcome of reaction 'Death'? | Radiation Therapy for Chemotherapy Refractory Gingival Myeloid Sarcoma.
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingiv... | Fatal | ReactionOutcome | CC BY | 34046361 | 20,096,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sudden death'. | Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
Mitotane has been used for the treatment of adrenocortical cancer (ACC) for over 50 years. Despite its widespread use both in monotherapy and in combination with chemotherapeut... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY | 34046364 | 19,399,141 | 2021 |
What was the dosage of drug 'HYDROCORTISONE'? | Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
Mitotane has been used for the treatment of adrenocortical cancer (ACC) for over 50 years. Despite its widespread use both in monotherapy and in combination with chemotherapeut... | 30 mg (milligrams). | DrugDosage | CC BY | 34046364 | 19,399,141 | 2021 |
What was the dosage of drug 'MITOTANE'? | Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
Mitotane has been used for the treatment of adrenocortical cancer (ACC) for over 50 years. Despite its widespread use both in monotherapy and in combination with chemotherapeut... | MAINTENANCE DOSE BETWEEN 2 AND 2.5 G PER DAY FOLLOWING 2 MONTHS OF TITRATION | DrugDosageText | CC BY | 34046364 | 19,399,141 | 2021 |
What was the outcome of reaction 'Sudden death'? | Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
Mitotane has been used for the treatment of adrenocortical cancer (ACC) for over 50 years. Despite its widespread use both in monotherapy and in combination with chemotherapeut... | Fatal | ReactionOutcome | CC BY | 34046364 | 19,399,141 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | CEFAZOLIN, CEFTAZIDIME, DINOPROSTONE, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34046414 | 20,128,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | CEFAZOLIN, CEFTAZIDIME, DINOPROSTONE, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34046414 | 20,128,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella bacteraemia'. | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | CEFAZOLIN, CEFTAZIDIME, DINOPROSTONE, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34046414 | 20,128,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | CEFAZOLIN, CEFTAZIDIME, DINOPROSTONE, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34046414 | 20,128,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | CEFTAZIDIME, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34046414 | 19,957,024 | 2021 |
What was the administration route of drug 'CEFAZOLIN'? | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34046414 | 20,128,788 | 2021 |
What was the administration route of drug 'DINOPROSTONE'? | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | Vaginal | DrugAdministrationRoute | CC BY | 34046414 | 20,128,788 | 2021 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | Recovered | ReactionOutcome | CC BY | 34046414 | 20,128,788 | 2021 |
What was the outcome of reaction 'Klebsiella bacteraemia'? | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | Recovered | ReactionOutcome | CC BY | 34046414 | 20,128,788 | 2021 |
What was the outcome of reaction 'Klebsiella infection'? | Post-partum Coronavirus Disease 19 Like Pneumonia Before the COVID-19 Italian Pandemic Outbreak: A Case Report.
Here we present a case of severe post-partum pneumonia that we observed at the end of January 2020. Specimen of blood was cultured and revealed Klebsiella pneumoniae bacteremia. However, the course of infecti... | Recovered | ReactionOutcome | CC BY | 34046414 | 20,128,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | DEXTROSE, PHENOBARBITAL, PHYTONADIONE, TACROLIMUS, URSODIOL | DrugsGivenReaction | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated intravascular coagulation'. | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | DEXTROSE, PHENOBARBITAL, PHYTONADIONE, TACROLIMUS, URSODIOL | DrugsGivenReaction | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | DEXTROSE, PHENOBARBITAL, PHYTONADIONE, TACROLIMUS, URSODIOL | DrugsGivenReaction | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | DEXTROSE, PHENOBARBITAL, PHYTONADIONE, TACROLIMUS, URSODIOL | DrugsGivenReaction | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the administration route of drug 'PHYTONADIONE'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the dosage of drug 'PHYTONADIONE'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | UNK, VITAMIN K SUPPLEMENTATION | DrugDosageText | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the dosage of drug 'URSODIOL'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | 20 MILLIGRAM/KILOGRAM (PER DAY) | DrugDosageText | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the outcome of reaction 'Adrenal haemorrhage'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Fatal | ReactionOutcome | CC BY-NC | 34046462 | 20,771,955 | 2021-05-26 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Recovered | ReactionOutcome | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the outcome of reaction 'Disseminated intravascular coagulation'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Fatal | ReactionOutcome | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Fatal | ReactionOutcome | CC BY-NC | 34046462 | 20,786,543 | 2021-05-26 |
What was the outcome of reaction 'Sepsis'? | Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
BACKGROUND
Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We ... | Fatal | ReactionOutcome | CC BY-NC | 34046462 | 20,771,955 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,899,211 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,884,564 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,947,136 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Motor dysfunction'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,947,136 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,899,211 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic arthritis staphylococcal'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,947,136 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | CORTISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,908,325 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | ACETAMINOPHEN, CORTISONE, IBUPROFEN, METHYLPREDNISOLONE SODIUM SUCCINATE, OXYCODONE | DrugsGivenReaction | CC BY-NC | 34046463 | 20,947,136 | 2021-05-26 |
What was the administration route of drug 'ACETAMINOPHEN'? | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | Oral | DrugAdministrationRoute | CC BY-NC | 34046463 | 20,884,564 | 2021-05-26 |
What was the administration route of drug 'CORTISONE'? | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | Other | DrugAdministrationRoute | CC BY-NC | 34046463 | 20,947,136 | 2021-05-26 |
What was the administration route of drug 'IBUPROFEN'? | Postoperative pain due to an occult spinal infection: A case report.
BACKGROUND
A high degree of vigilance is warranted for a spinal infection, particularly in a patient who has undergone an invasive procedure such as a spinal injection. The average delay in diagnosing a spinal infection is 2-4 mo. In our patient, the ... | Oral | DrugAdministrationRoute | CC BY-NC | 34046463 | 20,884,564 | 2021-05-26 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.